About

Publications While At HealthPartners

selected publications

Journal Article

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. 

Diabetes, Obesity & Metabolism. 2017

Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. 

Hypertension (Dallas, Tex.. 2016

Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. 

Diabetes care. 2016

Liraglutide and cardiovascular outcomes in type 2 diabetes. 

New England Journal of Medicine. 2016

Alogliptin after acute coronary syndrome in patients with type 2 diabetes. 

New England Journal of Medicine. 2013

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 

American Heart Journal. 2013

EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. 

American Heart Journal. 2011

Abstract

Mortality findings from the EXAMINE Trial [abstract]. 

Diabetes. 2016

Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract]. 

Diabetes. 2015

Contact

full name

S. E. Nissen

Quick Info

 

Collaboration

Co-author network

Map of science